SCHEMBL6637451

SCHEMBL6637451

NC(=O)c1occc1-c1ccc(O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.41
FYN P06241 1/20 0.39
CA2 P00918 1/20 0.38
HSD17B10 Q99714 2/20 0.38
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
ESR2 Q92731 5/20 0.37
USP7 Q93009 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
NPC1 O15118 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GAPDH P04406 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6633897 0.85 MAPK14 (0.45) NPC1ALDH1A1RAB9ACYP1A2CYP3A4
SCHEMBL6634313 0.84 GRM2 (0.41) HSD17B10NPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL6632966 0.84 IKBKB (0.41) FYNHSD17B10NPC1ALDH1A1HPGD
SCHEMBL10434450 0.84 LMNA (0.45) HSD17B10NPC1ALDH1A1HPGDRAB9A
SCHEMBL3983853 0.83 HSD17B10 (0.47) ESR1CA2HSD17B10CHRM2CHRM4
SCHEMBL3033548 0.83 BCAT2 (0.50) HSD17B10NPC1ALDH1A1RAB9AGAA
SCHEMBL8023283 0.82 PARP10 (0.46) ALDH1A1PARP10
SCHEMBL3975038 0.80 MAPK14 (0.47)
SCHEMBL6633617 0.80 PARP10 (0.49) CA2ALDH1A1SMN1; SMN2L3MBTL1KDM4E
SCHEMBL11127798 0.76 POLB (0.37) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1442041-A1 AZABICYCLIC-SUBSTITUTED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-08-04 EP disclosed
WO-2003040147-A1 AZABICYCLIC-SUBSTITUTED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE__________________________________________________________________________________________________________________________ PHARMACIA & UPJOHN COMPANY (US) 2003-05-15 WO disclosed